Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Merry Jennifer Markham

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
Journal of Oncology Practice|November 28, 2012
Evaluating the quality of colorectal cancer care in the state of Florida: results from the Florida Initiative for Quality Cancer CareErin M Siegel, Paul B Jacobsen, Mokenge Malafa, et al.
Journal of Oncology Practice|April 17, 2014
Changes in the care of non-small-cell lung cancer after audit and feedback: the Florida initiative for quality cancer careTawee Tanvetyanon, Ji-Hyun Lee, William J Fulp, et al.
Journal of Oncology Practice|October 30, 2014
Florida Initiative for Quality Cancer Care: Changes in Psychosocial Quality of Care Indicators Over a 3-Year IntervalPaul B Jacobsen, Ji-Hyun Lee, William Fulp, et al.
Journal of Oncology Practice|November 2, 2011
Degree of variability in performance on breast cancer quality indicators: findings from the Florida initiative for quality cancer careJhanelle E Gray, Christine Laronga, Erin M Siegel, et al.
Journal of the American College of Surgeons|August 4, 2014
Florida Initiative for Quality Cancer Care: improvements in breast cancer quality indicators during a 3-year intervalChristine Laronga, Jhanelle E Gray, Erin M Siegel, et al.
Journal of Oncology Practice|March 2, 2012
Quality of care in non-small-cell lung cancer: findings from 11 oncology practices in FloridaTawee Tanvetyanon, Michelle Corman, Ji-Hyun Lee, et al.
JCO Precision Oncology|May 22, 2025
Erratum: Phase II Trial of the PARP Inhibitor, Niraparib, in BAP1 and Other DNA Damage Response Pathway-Deficient NeoplasmsThomas J George, Ji-Hyun Lee, David L DeRemer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2012
Effects of a brief multimedia psychoeducational intervention on the attitudes and interest of patients with cancer regarding clinical trial participation: a multicenter randomized controlled trialPaul B Jacobsen, Kristen J Wells, Cathy D Meade, et al.
JCO Precision Oncology|December 3, 2024
Phase II Trial of the PARP Inhibitor, Niraparib, in BAP1 and Other DNA Damage Response Pathway-Deficient NeoplasmsThomas J George, Ji-Hyun Lee, David L DeRemer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 6, 2016
Clinical Cancer Advances 2016: Annual Report on Progress Against Cancer From the American Society of Clinical OncologyDon S Dizon, Lada Krilov, Ezra Cohen, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Journal of Oncology Practice|November 28, 2012
Evaluating the quality of colorectal cancer care in the state of Florida: results from the Florida Initiative for Quality Cancer CareErin M Siegel, Paul B Jacobsen, Mokenge Malafa, et al.
Journal of Oncology Practice|April 17, 2014
Changes in the care of non-small-cell lung cancer after audit and feedback: the Florida initiative for quality cancer careTawee Tanvetyanon, Ji-Hyun Lee, William J Fulp, et al.
Journal of Oncology Practice|October 30, 2014
Florida Initiative for Quality Cancer Care: Changes in Psychosocial Quality of Care Indicators Over a 3-Year IntervalPaul B Jacobsen, Ji-Hyun Lee, William Fulp, et al.
Journal of Oncology Practice|November 2, 2011
Degree of variability in performance on breast cancer quality indicators: findings from the Florida initiative for quality cancer careJhanelle E Gray, Christine Laronga, Erin M Siegel, et al.
Journal of the American College of Surgeons|August 4, 2014
Florida Initiative for Quality Cancer Care: improvements in breast cancer quality indicators during a 3-year intervalChristine Laronga, Jhanelle E Gray, Erin M Siegel, et al.
Journal of Oncology Practice|March 2, 2012
Quality of care in non-small-cell lung cancer: findings from 11 oncology practices in FloridaTawee Tanvetyanon, Michelle Corman, Ji-Hyun Lee, et al.
JCO Precision Oncology|May 22, 2025
Erratum: Phase II Trial of the PARP Inhibitor, Niraparib, in BAP1 and Other DNA Damage Response Pathway-Deficient NeoplasmsThomas J George, Ji-Hyun Lee, David L DeRemer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2012
Effects of a brief multimedia psychoeducational intervention on the attitudes and interest of patients with cancer regarding clinical trial participation: a multicenter randomized controlled trialPaul B Jacobsen, Kristen J Wells, Cathy D Meade, et al.
JCO Precision Oncology|December 3, 2024
Phase II Trial of the PARP Inhibitor, Niraparib, in BAP1 and Other DNA Damage Response Pathway-Deficient NeoplasmsThomas J George, Ji-Hyun Lee, David L DeRemer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 6, 2016
Clinical Cancer Advances 2016: Annual Report on Progress Against Cancer From the American Society of Clinical OncologyDon S Dizon, Lada Krilov, Ezra Cohen, et al.
Pageof 8